868 related articles for article (PubMed ID: 16785411)
1. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo M; Wu JC; Park EE; Tanzella F
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma.
Lee SH; Lee SS; Jin SM; Kim JH; Rho YS
Laryngoscope; 2008 Apr; 118(4):659-62. PubMed ID: 18176339
[TBL] [Abstract][Full Text] [Related]
3. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and pathological analysis of central compartment dissection in patients with papillary thyroid cancer with negative clinical lymph node metastasis].
Fu JY; Wu Y; Wang ZY; An Y; Sun TQ; Xiang J
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):470-2. PubMed ID: 17686305
[TBL] [Abstract][Full Text] [Related]
5. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?
Roh JL; Park JY; Rha KS; Park CI
Head Neck; 2007 Oct; 29(10):901-6. PubMed ID: 17405173
[TBL] [Abstract][Full Text] [Related]
6. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
[TBL] [Abstract][Full Text] [Related]
7. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
8. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
11. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
Alvarado R; Sywak MS; Delbridge L; Sidhu SB
Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma.
Roh JL; Park CI
Cancer; 2008 Oct; 113(7):1527-31. PubMed ID: 18671238
[TBL] [Abstract][Full Text] [Related]
13. [The characteristics of papillary thyroid cancer lymph node metastasis and the clinical significance of central region cervical lymph node dissection].
Li Z; Qu XC; Cheng B
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1407-9. PubMed ID: 19094514
[TBL] [Abstract][Full Text] [Related]
14. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma].
Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009
[TBL] [Abstract][Full Text] [Related]
15. Routine bilateral central lymph node clearance for papillary thyroid cancer.
Sadowski BM; Snyder SK; Lairmore TC
Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
[TBL] [Abstract][Full Text] [Related]
16. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
17. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
[TBL] [Abstract][Full Text] [Related]
18. [The role of lymphadenectomy in the treatment of differentiated thyroid cancer].
Dănilă R; Popovici R; Andriescu L; Timofte D; Ungureanu MC; Găluşcă B; Dragomir C
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):129-34. PubMed ID: 17595858
[TBL] [Abstract][Full Text] [Related]
19. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid cancer: role of the lymph node dissection.
Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]